The existence of pancreatic lipase-related protein 1 (PLRP1) in vertebrates has been postulated based on the screening of pancreatic cDNA libraries from different species. In this paper, we report the presence of variable amounts of PLRP1 relative to colipase-dependent lipase (PL) in adults from several species. Only a very low lipase activity could be detected for native or recombinant PLRP1 using a large variety of substrates and conditions. Interestingly, this activity is dependent on the presence of bile salts and colipase and PLRP1 is shown to possess the same affinity as PL for colipase. Modelling investigations revealed some interesting differences between PLRP1 and PL, notably concerning substitutions in the C-terminal domain which might affect the bending motion of this domain relative to the N-terminal domain in PLRP1. The potential impact of these differences on the lack of lipase activity of PLRP1 was investigated using chimeric proteins designed by C-terminal domain exchange between dog PLRP1 and horse PL. Analysis of the catalytic properties of the chimera clearly indicated that the C-terminal domain exchange neither inactivates the horse enzyme nor results in an active dog PLRP1. From these findings, it can be concluded that the PLRP1 C-terminal domain is fully functional with respect to colipase binding. The lack of lipase activity or the still undetermined function of PLRP1 is likely to result mainly from particular features of the N-terminal domain.
Introduction
Under physiological conditions, the well characterized classical lipase (PL) requires the presence of colipase to overcome the inhibitory effect of amphipaths covering intestinal oil droplets. PL is made up of two domains, an N-terminal domain bearing the active site and a C-terminal domain devoted to colipase binding. The enzyme has been shown to possess two distinct conformations, an inactive closed conformation in which a special loop, the flap, covers the active site (Winkler et al., 1990) and an active open conformation resulting from the unmasking of the active site through a repositioning of the flap (Van Tilbeurgh et al., 1993) . Colipase is involved in the stabilization of the flap in the open conformation.
Screening of pancreatic cDNA libraries from various species clearly revealed the presence of two lipase-related proteins (PLRP1 and PLRP2) besides PL (Giller et al., 1992; Kerfelec et al., 1986; Wicker-Planquart and Puigserver, 1992; Wishart et al., 1993; Payne et al., 1994; Thirstrup et al., 1995) . Sequence alignment showed that the related proteins possess all the amino acids essential for catalysis and colipase binding. Owing to the high degree of identity between these lipases, it can be assumed that the related lipases possess the same twodomain molecular organization.
Up to now, except for rat (Wagner et al., 1994) , the presence of the lipase-related proteins in pancreas or pancreatic juice has not been ascertained. In the rat, it has been postulated that three genes submitted to separate regulatory controls (Payne et al., 1994) are encoding these proteins. During rat development, relatively high levels of PLRP1 and PLRP2 mRNA have been observed only for a short period of time around birth. PLRP2 has been found attached to the inner surface of the membranes of the zymogen granules and its secretion is under the control of cholecystokinin (Wagner et al., 1994) .
Therefore, the biological function of the lipase-related proteins has mainly been investigated using their recombinant form. Recombinant PLRP2 from different species was able to hydrolyse both phospholipids (Thirstrup et al., 1995; Jennens and Lowe, 1995) and triacylglycerols (Giller et al., 1992) and is only marginally dependent on the presence of colipase. A very low activity towards galactosyldiacylglycerols has also been reported for this protein (Andersson et al., 1996) . By contrast, no significant phospholipase or lipase activity could be detected for recombinant human (Payne et al., 1994) and rat (Giller et al., 1992) PLRP1.
In this paper, we report the presence of large amounts of PLRP1 in the adult dog and cat pancreas as compared with pig and rat. We investigated the physiological function of these proteins using a large variety of substrates as well as their ability to bind colipase. The properties of native PLRP1 were compared with those of the dog recombinant PLRP1. Moreover, in order to understand better the structure-function relationships of PLRP1, chimeric proteins designed by C-terminal domain exchange have been produced and their properties investigated.
Materials and methods
Dog, cat and rat acetonic pancreatic powders were obtained from Sigma (St Louis, MO). The BaculoGold Starter Package, pVL1393 and pAcGP67 transfer vectors were purchased from Pharmingen (San Diego, CA). X-Press medium was supplied by Boehringer Ingelheim. Fetal calf serum was purchased from Dutscher (France). Antibiotics were obtained from GIBCO BRL/Life Technologies (Copenhagen, Denmark), alkaline phosphatase-labelled goat anti-rabbit IgG from Sigma, Taq polymerase from Promega (Madison, WI) and restriction enzymes and T4 DNA ligase from New England Biolabs (UK).
Expression of the dog recombinant PLRP1
The dog PLRP1 cDNA encoding the mature protein, cloned into the pUC9 vector, was amplified by PCR experiments before cloning in the pAcGP67 transfer vector. The two oligonucleotides 5ЈϾGAAGATCTTAAGGAAGTTTGCϽ3Ј and 5ЈϾCGGAATTCCGCTAACAGGGCGTGϽ3Ј were used as the 5Ј and 3Ј primers, respectively. The built-in restriction sites (BglII for the 5Ј primer and EcoRI for the 3Јprimer) are in bold type. The sequence in italics encodes the first four Nterminal residues of the mature protein for the 5Ј primer and the last three C-terminal residues plus the stop codon of the PLRP1 for the 3Ј primer.
PCR experiments were carried out under standard conditions with 1 min at 94°C, 1 min at 51°C and 2 min at 72°C for 25 cycles. After purification, PCR fragments were digested with BglII and EcoRI and then cloned into the BamHI/EcoRI restriction sites of the pAcGP67 transfer vector. The strategy used for this construction results in an extension of three amino acids (ADL) at the N-terminal end of the secreted recombinant protein. The correct integration of the insert was checked by DNA sequencing according to the method of Sanger et al. (1971) . After purification by CsCl gradient ultracentrifugation, the selected plasmid (pAcDPL1) was used with baculovirus DNA for cotransfection into Sf21 insect cells as described in the baculovirus Expression Vector System Manual. A 500 ml Sf21 cell culture was infected with the purified and amplified recombinant virus (multiplicity of infection of 2) and the media were collected 5 days post-infection. After removal of the cells and debris by centrifugation, the culture media were extensively dialysed against distilled water (4°C, 24 h) before freeze-drying. The recombinant PLRP1 (rPLRP1) was further purified as described below.
Purification of recombinant and native PLRP1
The dog rPLRP1 was purified according to a two-step procedure. The above freeze-dried powder was resuspended in 20 ml of 50 mM Tris-HCl, pH 7.5, containing 0.2 M NaCl and 1 mM benzamidine. Insoluble material was removed by centrifugation and the clear supernatant was loaded on an Ultrogel AcA 54 column (170 ϫ 3 cm i.d.) equilibrated in the same buffer. Elution was carried out using the same buffer. The fractions containing rPLRP1 were pooled and dialysed against 20 mM Tris-HCl, pH 8.0, containing 5 mM NaCl. After removal of insoluble material by centrifugation, the supernatant was loaded on a HiTrap blue column (Pharmacia) equilibrated in the same buffer. Elution was performed by stepwise increase of the NaCl concentration of the buffer. The complete selective elution of the dog rPLRP1 was accomplished at a 0.3 M NaCl concentration.
A similar procedure was used to isolate native PLRP1 from dog, cat, rat and pig pancreatic powders with slight modifications. The powders were suspended in an appropriate volume of 20 mM Tris-HCl buffer, pH 8.0, containing 1 mM benzamidine, 0.1 mM phenylmethylsulfonyl fluoride and 0.1 mM 4-amidinophenylmethanesulfonyl fluoride. After gentle stirring for 1 h at 4°C, insoluble material was removed by centrifugation and the clear supernatant was loaded on to the AcA 54 column.
The purified protein concentrations were determined at 280 nm using a molecular absorption coefficient of 6.65 ϫ 10 -4 l/mol.cm for the recombinant and native lipases.
Gel electrophoresis and Western blotting
Electrophoresis on 10-12% polyacrylamide gels was carried out in the presence of SDS as described by Laemmli (1970) .
Western blots were performed according to Burnette (1981) . After electrophoresis, proteins were electroblotted on a PVDF membrane using 50 mM Tris-borate transfer buffer, pH 8.3. PVDF membranes were saturated for 10 min at room temperature by soaking in 5% skim milk in TBS (20 mM Tris-HCl, pH 7.5, 137 mM NaCl), containing 0.1% Tween 20. Then the saturated membranes were incubated for 10 min at room temperature with rabbit polyclonal anti-horse PL antibodies (1/10 000) or polyclonal anti-dog rPLRP1 antibodies (1/20 000). These latter antibodies were obtained by immunization of rabbit using rPLRP1 (Eurogentec). Immunodetection was carried out using alkaline phosphatase-labelled goat antirabbit IgG. In such conditions a specific response was observed for each type of lipase.
N-Terminal sequence analysis
The purified lipases (rPLRP1, native PLRP1 and PL) were submitted to N-terminal microsequencing. Stepwise Edman degradation was performed automatically using a gas-phase sequencer (Applied Biosystems, Model 470A). The resulting phenylthiohydantoins were analysed by HPLC using a C 18 column (Brownlee, 5 µm, 220 ϫ 2.1 mm i.d.). They were eluted using a gradient from 10 to 46% methanol in 7 mM sodium acetate buffer, pH 4.84. Protein blotting/protein overlay Native colipase (18 µg) was loaded on to a 15% anionic polyacrylamide gel prior to electroblotting on a PVDF membrane. The membrane was soaked for 30 min at room temperature in 5% skim milk in 10 mM Tris-HCl buffer, pH 7.5, containing 0.1 M NaCl and 5 mM CaCl 2 . The saturated membrane was then incubated for a few minutes with either PL or PLRP1 (10 -6 M), washed with the Tris-HCl buffer and then incubated with either anti-PL or anti-PLRP1 antibodies. Immunodetection was carried out as mentioned above. Spectrofluorimetric investigation of lipase/colipase binding Porcine colipase and either native or recombinant dog PLRP1 were dissolved in 10 mM Tris-HCl buffer, pH 7.5, containing 0.1 M NaCl. Fluorescence spectra were recorded at 25°C using a Kontron SFM 25 spectrofluorimeter driven by an Apple IIe computer and equipped with a thermostated cell and a magnetic stirring device. The excitation wavelength was 290 nm. Titration of either native or recombinant dog PLRP1 with porcine colipase was performed by successive addition of 2 µl aliquots of a stock solution of porcine colipase (3.6 ϫ 10 -4 M) to 2 ml of PLRP1 solution (10 -6 M). The stoichiometry of the binding (n) and the dissociation constant (K d ) were determined according to the Scatchard method. Activity measurements Lipase activity was measured titrimetrically at 25°C using emulsified substrates in 1 mM Tris-HCl buffer, pH 7.5 containing 0.1 M NaCl and 5 mM CaCl 2 . The assays were performed in either the absence or presence of bile salts and colipase. When long-chain triacylglycerols were used, the pH of the assay was raised to 8.5. Routine assays were performed using 0.11 M emulsified tributyrin in the presence of 1 mM NaTDC and a 3 molar excess of colipase. One unit corresponds to the release of 1 µmol of fatty acid per minute.
In order to measure very low activities accurately, lipase was assayed as described previously (Somma-Delpéro et al., 1995) using 2 mM emulsified tri[9,10-3 H]oleoylglycerol as the substrate (about 6 ϫ 10 6 d.p.m. per µmol) in 0.1 M Tris-HCl buffer, pH 7.4, containing 2 mM CaCl 2 and 1% defatted albumin. When indicated, colipase and/or NaTDC were added. The test tubes were preincubated for 10 min at 37°C before addition of the enzyme solution and assays were run at 37°C. At selected times, the reaction was stopped and the reaction rate was determined by measuring the released [ 3 H]oleic acid in the incubation medium after extraction using a liquid-liquid partition phase (Boyer et al., 1981; Vérine et al., 1982) . One milliunit (mU) of lipolytic activity corresponds to the hydrolysis of 1 nmol of ester bond per minute.
Modelling
The dog PLRP1 structural model was constructed on the basis of the crystal structure of the highly homologous porcine pancreatic lipase (Hermoso et al., 1996) sharing 67% amino acid sequence identity. Amino acid sequence changes were incorporated using the graphics program O (Jones et al., 1991) running on a Silicon Graphics workstation. Side chain conformations were chosen from the database of more common conformers (Ponder and Richards, 1987 ). The initial model was first energy minimized using the Powell minimizer of X-PLOR (Brunger, 1988) . The Engh and Huber force field (Engh and Huber, 1991) was used in all energy minimizations and molecular dynamics simulations. In a second step, the slow-cooling molecular dynamics protocol of Brunger et al. (1990) with the weak temperature-coupling method of Berendsen et al. (1984) was applied: target temperature starting at 1000 K, temperature decrements of 25 K every 100 steps, final temperature 300 K. The time step was set to 0.05 fs during the molecular dynamics stages. Finally, the conformation trapped at 300 K was subjected to 500 steps of energy minimization.
Electrostatic potentials at the surface of the final PLRP1 molecule were calculated and visualized with the program GRASP (Nicholls et al., 1991) Construction and expression of chimeric proteins Chimeric proteins made of a classical lipase domain and a PLRP1 domain were constructed as described in Figure 1 . The plasmids pAcDPL1 and pVLHPL containing the cDNAs encoding dog PLRP1 and horse PL, respectively, were used for construction. The plasmid pVLHPL was constructed by insertion, at the EcoRI site of pVL1393, of an EcoRI fragment containing the horse PL cDNA excised from pSGLip (Ayvazian et al., 1996) . An EagI restriction site was introduced by sitedirected mutagenesis in each cDNA at the junction between the N-terminal and C-terminal domains, as indicated in Figure 1 . Owing to the building of the EagI site the alanine residue located in position 337 was substituted for a glycine residue without any modification of the reading frame. After digestion by EagI, both plasmids were submitted to electrophoresis on polyacrylamide gel and the resulting EagI restriction fragments were electroeluted. The small fragment encoding the horse PL C-terminal domain was cloned in the EagIdigested pAcDPL1 plasmid containing the cDNA encoding the dog PLRP1 N-terminal domain. Conversely, the small fragment encoding the dog PLRP1 C-terminal domain was cloned in the EagI-digested pVLHPL plasmid containing the cDNA encoding the horse PL N-terminal domain. Consequently, the first plasmid (named pHD1) encodes the chimeric protein (HD1) made of the horse PL N-terminal domain and the dog PLRP1 C-terminal domain. The second plasmid (named pD1H) encodes the chimeric protein (D1H) made of the dog PLRP1 N-terminal domain and the horse PL C-terminal domain. These two plasmids were subsequently used for The plasmids pHD1 and pD1H were constructed as indicated in Materials and methods. The primers used to introduce the EagI site in pAcDPL1 and pVLHPL were 5ЈϾGATTCCAGCAATGGCCGCTGGAGAT ACGG-GGϽ3Ј and 5ЈϾGATGCCAGCAATTTCGGCCGTTGGAGGTATA-GGGϽ3Ј, respectively. cotransfection experiments with baculovirus DNA into Sf21 cells.
Results

Production of recombinant dog PLRP1
In order to express PLRP1 as a secreted protein, the cDNA encoding the mature protein was cloned in the pAcGP67 transfer vector, downstream from the sequence encoding the signal sequence of the baculovirus GP 67 glycoprotein, the expression of which is driven by the polyhedrin promoter. The expression of the recombinant protein (rPLRP1) in Sf21 insect cells was performed as described in Materials and methods. Owing to the lack of significant activity of the protein, an immunodetection of rPLRP1 in the culture supernatant was performed during the production using anti-horse PL antibodies. The amount of secreted rPLRP1 was estimated to be roughly 20 mg/l.
Analysis of purified rPLRP1 by SDS-PAGE showed the presence of a single band with the expected molecular weight (50 kDa). Microsequencing of the purified rPLRP1 yielded the N-terminal sequence ADLKEVCYEQ, corresponding to the three N-terminal amino acid extension resulting from the genetic construction followed by the N-terminal sequence of Fig. 2 . Immunoblotting of dog rPLRP1 and native horse and dog PL. 12% SDS-PAGE electrophoresis was performed on samples containing 0.2 µg of the purified proteins. Transfer conditions and immunodetection using either anti-PL (lanes 1-3) or anti-rPLRP1 (lanes 4-6) antibodies were as indicated in Materials and methods. Lanes 1 and 4, dog rPLRP1; lanes 2 and 5, horse PL; lanes 3 and 6, dog PL. the mature PLRP1 (Kerfelec et al., 1986) . This result indicates that the cleavage of the signal sequence by the insect signal peptidase occurred at the correct place in the preprotein.
Isolation of native PLRP1 from various species
Polyclonal antibodies raised against dog rPLRP1 proved to be useful tools in the specific detection of PLRP1 in pancreas or pancreatic juice. As shown in Figure 2 , anti-PL antibodies (raised against horse PL) and anti-rPLRP1 antibodies gave specific responses. Both horse and dog PL strongly react with anti-PL antibodies but very poorly with anti-rPLRP1 antibodies. Conversely, dog rPLRP1, which is strongly recognized by anti-rPLRP1 antibodies, is only moderately detected using anti-PL antibodies. Since PLRP1 displays no detectable activity on routine tests, the difference in specificity of anti-PL and anti-PLRP1 antibodies was used to detect the presence of PLRP1 in the pancreas from various species (dog, cat, pig and rat).
Ultrogel AcA 54 molecular sieving performed on dog pancreatic powder yielded a well defined peak presenting lipase activity. The proteins contained in this peak strongly reacted with both anti-PL and anti-PLRP1 antibodies. With respect to lipase activity and antibody responses, the peak was slightly asymmetric. The lipase activity and response to anti-PL antibodies were shifted towards the descending part of the peak, the ascending part exhibiting a weak lipase activity but a strong response to anti-PLRP1 antibodies. Further purification on a HiTrap blue column led to a complete separation of two 50 kDa proteins. The first protein eluted at low ionic strength displayed lipase activity and a strong positive response to anti-PL antibodies. Increasing the ionic strength led to the elution of a protein strongly recognized by anti-PLRP1 antibodies and devoid of significant lipase activity (Figure 3) . The same purification protocol was applied to cat, rat and pig pancreatic powders and yielded similar results, although some differences in the chromatographic behaviour were observed according to the species.
All the inactive lipases present an N-terminal sequence either identical with or closely related to the known sequences of PLRP1, whereas the N-terminal sequences of the active lipases are closely related to those of PL (Table I) . Therefore, based on both their N-terminal sequence and their immunological response, the inactive proteins purified from dog, cat, rat and pig pancreas can be identified as protein lipase-related Fig. 3 . Purification of dog PLRP1 by chromatography on Hitrap blue. After dialysis against 20 mM Tris-HCl buffer, pH 8.0, containing 5 mM NaCl and 1 mM benzamidine, the fractions eluted from AcA 54 Ultrogel containing the 50 kDa lipases were loaded on a Hitrap blue prepacked column (5 ml) equilibrated using the same buffer. After washing, elution was performed by stepwise increase of the ionic strength of the buffer (NaCl: a, 5; b, 50; c, 100; d, 300 mM). Flow rate, 30 ml/h. Fraction volume, 3 ml. Solid line, absorbance at 280 nm; dashed line, lipase activity. Inset: 12% SDS-PAGE of fractions (1) 45 and (2) 68; (3) molecular weight markers: 94, 67, 43, 30, 20.5 and 14 kDa.
proteins of type 1. It must be pointed out that the amount of PLRP1 with respect to PL varies significantly according to the species. PLRP1 was at least as abundant as PL in dog and cat, whereas relatively low levels of PLRP1 were detected in rat and pig.
The same purification procedure was applied to dog pancreatic juice (a generous gift from Dr Lombardo) and allowed us to isolate PLRP1, thus indicating that PLRP1 is likely to be a secreted protein.
Catalytic properties of native and recombinant dog PLRP1
In order to detect an eventual strict substrate specificity, the catalytic properties of native PLRP1 were investigated titrimetrically (Metrohm pH-stat) using a large variety of emulsified substrates as indicated in Table II . All the substrates, except for monoolein and diolein, were used at concentrations slightly above the reported concentration of dietary lipids (40 mM). The assays were performed in either the absence or presence of colipase and bile salts.
Native and recombinant PLRP1 displayed no measurable hydrolytic activity towards emulsified substrates in the absence of colipase and bile salts. In the presence of colipase and micellar concentrations of bile salts, a very low activity towards either pure triacylglycerols or natural oils could be detected. These activities were not dependent on the nature of the bile salts since the same values were obtained using either sodium cholate, taurocholate, taurodeoxycholate, deoxycholate or total bile salts. Varying the pH of the assay from 5.5 to 8.5 did not reveal any higher activity. PLRP1 was found to be inactive towards some triacylglycerols bearing long-chain fatty acid with two or more unsaturations. PLRP1 also displayed a weak activity towards diacylglycerols, two orders of magnitude lower than that observed with PL. PLRP1 was found to be inactive on 2-monooleoylglycerol, digalactodiacylglycerols and phospholipids. The activity of PLRP1 was also unsuccessfully tested on mixtures containing various triacylglycerols, phospholipids and free fatty acids. Since no activity could (Kerfelec et al., 1986) and rat (Payne et al., 1994) cDNAs. c From Hermoso et al. (1996) . d From Sims et al. (1992) . The chain length and unsaturation are indicated in parentheses. Except for monoolein and diolein, for which the concentration used was 10-20 mM, all the substrates were used at 0.1-0.15 M. See Materials and methods for experimental conditions. n.m., Not measurable. a This value was checked using the microtitration method. b The cleavage of the amide bond was tested using this substrate.
be detected with these substrates at concentrations slightly exceeding the physiological concentration of dietary lipids, it did not seem relevant to test higher substrate concentrations. Assays performed in synergy with pancreatic lipase and/or phospholipase A2 did not revealed any significant PLRP1 activity. Interestingly, however, PLRP1 reduced PL activity towards emulsified tributyrin in the presence of colipase and bile salts, but full PL activity was recovered upon further colipase addition, indicative of a competition for colipase between PLRP1 and PL. The capability of native PLRP1 to hydrolyse amide bonds was also investigated using sphingolipids. No activity could be detected using the radiolabelled nickel procedure (Ho, 1970) . The effect of colipase and bile salts on PLRP1 activity was studied using radiolabelled emulsified tri[9,10-3 H]oleoylglycerol as substrate. The activity was tested in either the absence or presence of colipase and/or bile salts. As controls, the activity of dog rPLRP1 and PL was assayed in the same conditions. The results are reported in Table III , where they are compared with those obtained under the same conditions with PL. Both native and recombinant PLRP1 displayed a very low hydrolytic activity as compared with PL. However, it must be stressed that, as in the case of PL, PLRP1 activity was significantly increased in the presence of both colipase and 4 mM NaTDC. Either native or recombinant PLRP1 exhibited a maximal specific activity of 1-3 U/mg, which was at least three orders of magnitude lower than that of PL under the same conditions. As in the case of PL, PLRP1 lipolytic activity was consistently lowered by high NaCl concentrations (1 M).
Moreover, PLRP1 was inhibited by diethyl p-nitrophenylphosphate (E600) under the same conditions as those described for PL (Hermoso et al., 1996) . Incubation at 20°C and pH 6.0 of PLRP1 (10 -6 M in 0.1 M MES buffer containing 0.1 M NaCl) with E600 (1 mM) for 1 h in the presence of colipase and 4 mM NaTDC resulted in 80% inhibition of The activities were determined using either 0.11 M emulsified tributyrin or 2 mM radiolabelled triolein. n.m., Not measurable; n.d., not determined. PLRP1 activity. As in the case of PL, inhibition only occurred in the presence of colipase and NaTDC.
Colipase binding of PLRP1
The binding between native dog PLRP1 and porcine colipase was investigated using the protein blotting/protein overlay assay (Figure 4) . The strips containing colipase were soaked either in a 1 µM dog PL (lane 3) or 1 µM dog PLRP1 (lane 4) solution before immunodetection with either anti-PL or anti-PLRP1 antibodies, respectively. In both cases, a positive response was obtained, indicative of binding between colipase and either PL or PLRP1. Control experiments performed on PVDF strips containing only colipase showed that neither anti-PL (lane 1) nor anti-PLRP1 (lane 2) antibodies recognized porcine colipase. Spectrofluorimetric studies gave a K d value of 10 -7 M and a stoichiometry of 1 for the binding of dog PLRP1 to colipase. The K d value was very similar to that determined in the case of PL (Ayvazian et al., 1996) . Modelling The levels of sequence identity and homology between various PL and PLRP1 are 67 and 81%, respectively. When calculated for each domain, the sequence identity and homology between the N-terminal domain of various PL and PLRP1 are 70 and 84%, respectively. In the case of the C-terminal domain, these values are 58 and 78%, respectively. Based on these data, one can conclude that the difference in conservation of one domain relative to the other does not look very significant. Moreover, the residues known to play an important role in catalysis (catalytic triad, oxyanion hole and colipase binding) are conserved as well as the residues forming the flap. However, sequence alignment of PL and PLRP1 revealed some interesting differences between the two proteins. Two non-conserved sequences are of special interest since they belong to loops which are close to the N-terminal domain. In the first one (residues 389-391), a lysine (K390) in PLRP1 is in place of an aspartic acid (D390) in PL. In the second (residues 424-428), where no strict identity is observed, an insertion (G425a) and the presence of a lysine (K427) in place of a glycine (G427) in PLRP1 as compared with PL deserve special attention.
Modelling investigations of dog PLRP1 based on the 3D structure of porcine PL (Hermoso et al., 1996) did not reveal any particular feature. In the N-terminal domain, the important stretches of sequence corresponding to the β 5 , β 6 and β 9 loops, althought not strictly conserved, do not lead to significant conformational changes in the model. In addition, the Cterminal domain is likely to possess a properly formed colipase binding site. However, inspection of the model indicated that some interactions, which do not occur in PL, might affect either the relative orientation of the N-and C-terminal domains or the bending motion of the C-terminal domain relative to the N-terminal domain (Hermoso et al., 1996) in PLRP1 and therefore, by side effects, prevent PLRP1 from adopting a correct open conformation. Thus, K390 and K427 belonging to the C-terminal domain are likely to make ion pairs with D332 and D303, respectively, located in the N-terminal domain. Moreover, the presence of G425a might induce steric hindrance.
Exchange domain between PL and PLRP1
In order to check the functionality of the PLRP1 C-terminal domain, chimeric proteins designed by C-terminal domain exchange between horse PL and dog PLRP1 were constructed and expressed in insect cells. For the sake of clarity, the chimeric protein made of the N-terminal domain of horse PL and of the C-terminal domain of dog PLRP1 was named HD1. Conversely, the other chimeric protein bearing the N-terminal domain of dog PLRP1 and the C-terminal domain of horse PL was named D1H. SDS-PAGE analysis showed that the chimeric proteins expressed in insect cells possessed the correct size. As expected from their calculated molecular weights, D1H (51 kDa) has a slightly larger size than HD1 (50 kDa). Equivalent amounts of horse PL and HD1 (about 10 mg/l) were produced in the supernatants of the culture media. A better yield (about 20 mg/l) was observed for dog PLRP1 and D1H.
The chimeric proteins were purified using a one-step procedure. HD1 was isolated by chromatography on HiTrap blue ( Figure 5A ) under the same conditions as dog rPLRP1. D1H, which was not retained on HiTrap blue, was purified by chromatography on DE-Trisacryl ( Figure 5B ). As shown in Figure 6 , in contrast to horse PL and dog PLRP1, the chimeric proteins could be detected using both anti-PL anti-PLRP1 antibodies.
The activities of the recombinant horse PL, dog PLRP1 and chimeric proteins were tested using emulsified tributyrin in either the absence or presence of NaTDC and colipase. The results presented in Table IV show that HD1 retains 70% of the horse PL activity. Moreover, the chimeric protein was inhibited by the presence of bile salts and its activity was restored by colipase, as observed with horse PL. No significant activity on emulsified tributyrin could be detected in the case of D1H. Nevertheless, D1H retains 70% of dog PLRP1 activity using the radiolabelled triolein assay and this activity is still dependent on the presence of colipase and bile salts. These findings clearly indicate that the C-terminal domain interchange neither inactivates the horse enzyme nor results in a more catalytically efficient dog PLRP1.
Discussion
Although PLRP1 has been postulated to be expressed for only a short period of time around birth (Payne et al., 1994) , significant amounts of this protein were found in adult animals of all the species studied. The pancreas of dog and cat synthesizes equivalent amounts of PLRP1 and PL, whereas in rat and pig smaller amounts of PLRP1 were found. Since the physiological function of PLRP1 has still to be determined, the presence of such high levels of this protein in the pancreas of dog and cat could not easily be interpreted. The finding of PLRP1 in pancreatic juice implies that this protein is produced by the exocrine pancreas.
Although we used a large variety of substrates and various conditions, we were unable to identify the function of PLRP1. Nevertheless, the finding that the very weak lipase activity and the inhibition by E600 of PLRP1 are dependent on the presence of both bile salt micelles and colipase leads us to postulate, by analogy with PL, that in solution PLRP1 adopts an inactive closed conformation and that bile salt micelles and colipase are involved in the opening of the flap (Hermoso et al., 1996) , thus converting PLRP1 to a more active conformation. However, the PLRP1 'open' conformation is unable to hydrolyse classical lipase substrates at physiological concentrations. Therefore, with the restriction of a very specific function not evidenced during our assays, requiring either a different substrate and/or specific cofactors, the possibility that PLRP1 could be unable to perform catalysis due to the presence of either a defective N-terminal or C-terminal domain, or both, cannot be ruled out. From modelling investigations, it was postulated that a steric hindrance between the N-and Cterminal domains of PLRP1 could arise from the presence of an additional residue (G425a) in the loop 420-430. In addition, the bending motion between the N-and C-terminal domains occurring during the repositioning of the flap (Van Tilbeurgh et al., 1993; Hermoso et al., 1996) is likely to be hampered in PLRP1 by ion pairing between K390 and D332 and between K427 and D303.
Investigation of PLRP1/colipase binding using the protein blotting/protein overlay method as well as differential spectrofluorimetry confirmed the kinetic studies and showed that in solution, colipase binds to PLRP1 with a stoichiometry of 1 and a K d value similar to that observed for active PL (Ayvazian et al., 1996) . These results, however, did not give any information about an appropriate orientation of colipase upon binding on PLRP1. In order to check the capability of the PLRP1 Cterminal domain of forming an efficient complex with colipase, a chimeric protein HD1, made up of the N-terminal domain of active horse PL and of the C-terminal domain of dog PLRP1, was constructed. The chimeric protein expressed in insect cells displayed a catalytic behaviour similar to that of native horse PL. HD1 retained at least 70% activity on emulsified tributyrin. The chimera was inhibited by supramicel-lar NaTDC concentrations and its activiy was restored by colipase. These results clearly indicate that the HD1/colipase complex is functional in the presence of a bile salt-coated substrate interface. Therefore, it can be concluded that the PLRP1 C-terminal domain properly binds colipase.
Moreover, substituting the C-terminal domain in PLRP1 for that of horse PL would be expected to preserve the bending motion between the two domains in the resulting chimeric protein D1H. Nevertheless, D1H did not display any higher catalytic activity than PLRP1, but retained the catalytic behaviour of PLRP1. These findings indicate that the apparent inactivity of PLRP1 does not result from a defective Cterminal, but more likely arises from a 'divergent' N-terminal domain as compared with the PL N-terminal domain. Whether the PLRP1 N-terminal domain acquired a new specific function or, less attractive, became catalytically inefficient remains an open question. In all cases, the physiological function of PLRP1 remains to be determined.
